AZD1775 (adavosertib)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AZD1775 (adavosertib), covering 2026-01-30 to 2026-01-30. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Trial of AZD1775 and Belinostat in Treating Patients With Relapsed or Refractory Myeloid Malignancies or Untreated Acute Myeloid Leukemia [Phase 1]